Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

AGEN

AGEN News

Newswire

01:44

Agenus Inc. Analyst Call: Bot/Bal Immunotherapy Program Update

08:51

Agenus Appoints José Iglesias as Chief Medical Affairs Officer to Lead Global Medical Affairs and Early-Access Programs, Including France's AAC

16:57

Agenus Q3 Earnings and Revenue Miss Estimates, Zacks Rank Remains at Hold

12:57

Agenus shares surge 11.21% intraday after reporting Q3 clinical advances and France regulatory approvals.

07:37

Agenus Reports Q3 2025 Results with France Granting Reimbursed Access to BOT/BAL Treatment.

View More

About AGEN

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More